Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04273087 · ClinicalTrials.gov registry record
Characterization of a Clinical Subpopulation With Autism Spectrum Disorder
A clinical trial, sponsored by Stalicla.
- Completed
- Registry status
- 236
- Enrollment target
NCT04273087: Completed study, sponsored by Stalicla.
NCT04273087 is a clinical trial that has completed, run by Stalicla. The registered enrollment target is 236 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04273087 has completed, sponsored by Stalicla.
- COMPLETED
- Registry status
- 236 participants
- Enrollment target
Study Summary
The main objective for this research study is to gather additional information to help confirm identification of new subgroups within the autism spectrum.
Primary Outcome
A questionnaire will be administered to collect non-behavioral traits and co-occurring conditions data of the participants
Interventions
- OTHER Observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 236 participants |
| Start Date | 2020-06-04 |
| Est. Completion | 2022-10-31 |
What the finished NCT04273087 record still lists
NCT04273087 is an observational study that tracks outcomes without assigning an intervention. The registered 236 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Observation is the first listed.
NCT04273087 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04273087 about?
NCT04273087 is a clinical study titled "Characterization of a Clinical Subpopulation With Autism Spectrum Disorder". The main objective for this research study is to gather additional information to help confirm identification of new subgroups within the autism spectrum.
What is the current status of trial NCT04273087?
This trial is currently completed. The enrollment target is 236 participants. The study started on 2020-06-04. Estimated completion is 2022-10-31.
What interventions are being tested in trial NCT04273087?
The interventions under investigation include: Observation (OTHER).
Who is sponsoring clinical trial NCT04273087?
This trial is sponsored by Stalicla, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04995341 · 236 participants · NA
Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)
- NCT05822362 · 236 participants · Phase 2
CBD for Individuals at Risk for Alzheimer's Disease
- NCT06200103 · 236 participants · Phase 2
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
- NCT06494072 · 236 participants · Phase 4
Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI